contact us sitemap korean
     
Introduction
Ideology
CEO Message
Company Policy
Company Profile
CI
Vision
Branch office & Map
Organization
Information Data

Introduction

 

Company Introduction

 

1. Date of Establishment : Sep. 1st, 1983
 
2. Date of Corporation founded : Jul. 8th, 1986 (a registration number-1151)
 
3. Line of Business
 

① Manufacture, wholesale, export and import of pharmaceuticals
② Selling of chemicals (with exception of a poison and chemical class)
③ A wholesale business of non-pharmaceuticals
④ The publication of a document definite promise about sale and delivery
⑤ Division of labor of pharmaceuticals
⑥ The business articles of food (health food)
⑦ All the business attached to each an item

 
4. Capital : 3,528,450,000 won (USD 3.8Mil) / A stock issues : 705,690 shares
 
5. The Board of Directors
  * President (Mr. K. H. Lee)
* Vice President (Mr. S. M. Woo, Mr. H. K. Son)
* Advisor (Mr. B. S. Min)
* Managing Director (Mr. P. Y. Soh, Mr. K. Chang)
* Executive Director (Mr. J. K. Ha, Mr. H. W. Seo, Mr. K. H. Choi, Mr. C. H. Bae)
* Director (Mr. J. H. Kim, Mr. C. S. Park)
* Outside Director (Dr. D. J. Lee)
 
6. The Production Facilities (In the Sangsin-Li, Hyangnam-Myun industrial complex)
  * The first Plant (Main Plant)
- A floor space of 5,470 ㎡ (1,655 p'yong)
* The second Plant (Warehouse)
- A floor space of 2,246 ㎡ (678 p'yong)
* The third Plant (Material Compounding Plant) - on construction
- A floor space of 892 ㎡ (270 p'yong)
* The Plant Site : 25,487㎡ (7,710 p'yong)
* Dormitory : 9 houses (each house 43㎡ (13 p'yong))
 
7. Products Composition
  - Surgery : 17 Items incl. Atroda
- Gastro Intestinal : 9 Items incl. Recosta
- Cardio Vascular : 18 Items incl. Cartin Inj.
- Obstetrics and Gynecology : 7 Items incl. Libron
- Antibiotics : 9 Items incl. Cefaclor
- Anesthesiology : 15 Items incl. Provive
- Obesity : 14 Items incl. Topamin
   
  8. Net sales : 52Mil US$ (47.9 Bil Won) (The end of year 2006)
   
  9. Net profit : 5.5Mil US$ (5.2Bil Won)
   
  10. Patent
  - A process for solubilizing aceclofenac
(Registration No. 10-069154, 2006.11.16)
- Novel Intermediate Compound for Valsartan and
Preparation Process of Valsartan Using thereof
(Open 10-2006-85073, 2006. 7. 26)
- Process for Manufacturing of Glimepiride
(Open 10-2005-17776, 2005.2.23)
- Novel Intermediate Compound for Amlodipine Besylate and
Preparation Process of Amlodipine Besylate Using thereof
(Open 10-2005-122481, 2005. 12. 29)
- Preparation Process of Lacidipine
(Application 10-2006-31654, 2006. 4. 6)
- Novel Intermediate Compound for Preparing Amlodipine, its Preparation
Process and Preparation Process of Amlodipine Using it
(Application 10-2006-103049, 2006. 10. 23)

 

 

Home
   
Myungmoon Pharm. Co., LTD.  MYUNGMOON B/D, 946-18, DOKOK-DONG, KANGNAM-KU, SEOUL, KOREA   TEL : 02-6711-2000
email